RULOYUS Trademark

Trademark Overview

On Monday, July 13, 2015, a trademark application was filed for RULOYUS with the United States Patent and Trademark Office. The USPTO has given the RULOYUS trademark a serial number of 86690926. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 28, 2022. This trademark is owned by Celgene Corporation. The RULOYUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
ruloyus

General Information

Serial Number86690926
Word MarkRULOYUS
Filing DateMonday, July 13, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 28, 2022
Registration Number4936093
Registration DateTuesday, April 12, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, October 28, 2022CANCELLED SEC. 8 (6-YR)
Monday, April 12, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, January 26, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 17, 2015ASSIGNED TO LIE
Thursday, December 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, December 5, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 5, 2015NON-FINAL ACTION E-MAILED
Saturday, December 5, 2015NON-FINAL ACTION WRITTEN
Friday, December 4, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 4, 2015FINAL REFUSAL E-MAILED
Friday, December 4, 2015FINAL REFUSAL WRITTEN
Tuesday, November 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 27, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 3, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 3, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 27, 2015ASSIGNED TO LIE
Tuesday, October 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 29, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2015NON-FINAL ACTION WRITTEN
Friday, September 18, 2015ASSIGNED TO EXAMINER
Thursday, July 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 16, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

ruloyus disease pharmaceutical preparations namely inflammation oncology fields immunology cytokine immune